Guerbet SA (GBT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Guerbet SA (GBT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7169
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guerbet SA (Guerbet) operates in the contrast-agent field. The company provides a wide range of pharmaceutical products, medical equipments and services for interventional imaging and diagnostic, to improve the diagnosis and treatment of patients. Its major products include diagnostic imaging products comprising contrast media for X-Ray imaging and magnetic resonance imaging (MRI); delivery systems and services; and interventional imaging products. Guerbet has presence in Europe, Asia, Oceania and North and South America. The company offers products directly through its sales structure, distributors and license-holders. Guerbet is headquartered in Villepinte, France.

Guerbet SA (GBT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guerbet SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guerbet SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guerbet SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Guerbet SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guerbet SA, Medical Equipment, Deal Details 10
Asset Purchase 10
Guerbet Acquires Contrast Media and Delivery Systems Business from Mallinckrodt for USD270 Million 10
Partnerships 11
Methapharm Enters into Distribution Agreement with Guerbet 11
Acquisition 12
Guerbet to Acquire Accurate Medical Therapeutics for up to USD68.6 Million 12
Guerbet SA – Key Competitors 13
Guerbet SA – Key Employees 14
Guerbet SA – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 18
Strategy And Business Planning 18
Jul 10, 2018: IBM Watson Health and Guerbet to use AI in medical imaging 18
Apr 18, 2018: GEAR 2023 strategic plan 19
Financial Announcements 21
Jul 26, 2018: GUERBET : Revenue at June 30 2018 21
Jun 25, 2018: GUERBET : 2018 half-year results 22
Apr 18, 2018: Guerbet reports 1st quarter 2018 revenue 24
Mar 27, 2018: Guerbet: 2017 Annual Results – Satisfactory activity slightly exceeding the objectives 25
Feb 15, 2018: GUERBET : 2017 revenue at constant exchange rates: €812.4 million; +4.7% 27
Oct 25, 2017: GUERBET: Revenue at September 30, 2017 29
Sep 26, 2017: GUERBET: 2017 half-year results 30
Jul 27, 2017: Guerbet: Revenue at June 30, 2017, satisfactory activity growth 31
Apr 27, 2017: GUERBET: 1st quarter 2017 revenue 32
Mar 29, 2017: GUERBET : 2016 annual results 33
Feb 15, 2017: GUERBET : 2016 Annual Revenue: €788.8 million, +7.1% growth in Q4 34
Corporate Communications 35
Jul 09, 2018: Guerbet Names Richard Hines as Head of Sales for New North American Interventional Imaging Division 35
Feb 19, 2018: David Hale Appoints Guerbet Executive Committee as Chief Commercial Officer, Diagnostic Imaging 36
Sep 04, 2017: Guerbet reinforces its digital innovative strategy Appointment of Francois Nicolas to the position of Chief Digital Officer 37
Product News 38
Feb 27, 2017: Guerbet Will Present Its Innovative Solutions for Medical Imaging at ECR 2017 38
Other Significant Developments 39
Jul 10, 2017: Guerbet Announces Plans to Streamline Its Contrast Media Portfolio 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Guerbet SA, Medical Equipment, Key Facts, 2017 2
Guerbet SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guerbet SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guerbet SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guerbet SA, Deals By Market, 2012 to YTD 2018 8
Guerbet SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guerbet Acquires Contrast Media and Delivery Systems Business from Mallinckrodt for USD270 Million 10
Methapharm Enters into Distribution Agreement with Guerbet 11
Guerbet to Acquire Accurate Medical Therapeutics for up to USD68.6 Million 12
Guerbet SA, Key Competitors 13
Guerbet SA, Key Employees 14
Guerbet SA, Other Locations 15
Guerbet SA, Subsidiaries 15

List of Figures
Guerbet SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Guerbet SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Guerbet SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guerbet SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Guerbet SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guerbet SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Guerbet SA (GBT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Nippon Synthetic Chemical Industry Co Ltd:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Electrica SA (EL):企業の財務・戦略的SWOT分析
    Electrica SA (EL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Quidel Corp (QDEL):医療機器:M&Aディール及び事業提携情報
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • Lannett Company Inc (LCI):企業の財務・戦略的SWOT分析
    Lannett Company Inc (LCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ConMed Corporation (CNMD):医療機器:M&Aディール及び事業提携情報
    Summary ConMed Corporation (ConMed) is a medical technology company which manufactures and sells surgical devices and instruments for minimally invasive procedures and monitoring. The company’s major products include arthroscopes, reconstructive systems, bronchoscopy devices endoscopic ligator kit, …
  • The Midcounties Co-operative:企業の戦略・SWOT・財務情報
    The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report Summary The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Enea AB (ENEA):企業の財務・戦略的SWOT分析
    Summary Enea AB (Enea) is a technology company that provides software solutions. The company offers embedded technologies, testing and validation, certifications, software outsourcing, research and development centers, professional staffing and packaged services. It offers realtime operating system …
  • Korn Ferry (KFY):企業の財務・戦略的SWOT分析
    Korn Ferry (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cepheid:医療機器:M&Aディール及び事業提携情報
    Summary Cepheid, a subsidiary of Danaher Corporation, is a molecular diagnostic company that develops, manufactures and markets molecular systems and tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious d …
  • United States Lime & Minerals Inc:企業の戦略・SWOT・財務分析
    United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Metro Pacific Investments Corporation:企業のM&A・事業提携・投資動向
    Metro Pacific Investments Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Metro Pacific Investments Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Xi’An Catering Co., Ltd.:企業の戦略・SWOT・財務分析
    Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • International Coffee & Tea, LLC:戦略・SWOT・企業財務分析
    International Coffee & Tea, LLC - Strategy, SWOT and Corporate Finance Report Summary International Coffee & Tea, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Damas International Ltd:企業の戦略・SWOT・財務分析
    Damas International Ltd - Strategy, SWOT and Corporate Finance Report Summary Damas International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Gem Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Gem Pharmaceuticals LLC (Gem Pharmaceuticals) is a clinical-stage biopharmaceutical company that develops proprietary anthracycline derivatives. The company’s pipeline products include GPX-150 for oncology, topical GPX-150 for inflammation, GPX 150 oral formulations and potency analogues pro …
  • The Aerospace Corp:企業の戦略的SWOT分析
    The Aerospace Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Arch Capital Group Ltd.:企業の戦略・SWOT・財務情報
    Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • ICICI Bank Ltd:戦略・SWOT・企業財務分析
    ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • WEC Energy Group:企業の戦略・SWOT・財務情報
    WEC Energy Group - Strategy, SWOT and Corporate Finance Report Summary WEC Energy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Gold Fields Limited:企業の戦略・SWOT・財務情報
    Gold Fields Limited - Strategy, SWOT and Corporate Finance Report Summary Gold Fields Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆